Subglottic Stenosis in Adults

Back

Practice Essentials

Subglottic stenosis, partial or complete narrowing of the subglottic area, may be congenital or acquired. The problem is rare and challenging, affecting soft tissue and cartilage support.

Iatrogenic injuries cause most of the problems seen. Often, subglottic stenosis has an insidious onset, and early manifestations are usually mistaken for other disorders (eg, asthma, bronchitis).

An image depicting subglottic stenosis can be seen below.



View Image

Preoperative view of subglottic stenosis via an endoscopic approach.

Workup in subglottic stenosis

Laboratory studies

In the absence of a history of prior trauma or when suggested by other findings, evaluate for inflammatory or infectious causes, including the following:

Imaging studies

Standard chest radiographs can often provide a great deal of information regarding the tracheal air column. Radiographic anteroposterior filtered tracheal views and lateral soft tissue views of the neck provide specific information regarding the glottic/subglottic air column.

Magnetic resonance imaging (MRI) is useful in evaluating length and width of the stenotic region by means of coronal and sagittal views.

Computed tomography (CT) scanning is not as helpful as MRI because its views are generally only in the axial plane. Thin cuts (1 mm) with sagittal and/or coronal reconstructions may be helpful, however.

Other

Videostrobolaryngoscopy is extremely helpful in evaluating the glottic and supraglottic larynx for possible concomitant injury.

Visualization of the larynx by flexible fiberoptic or rigid telescope (90- or 70-degree) scopes in the clinic is crucial to the evaluation of airway lesions.

Management of subglottic stenosis

Medical therapy

Antireflux management includes the following

Transcervical or transoral (via a channeled scope) injection of steroids such as triamcinolone acetonide (Kenalog-40) is being used by many centers, with good early results in the control of subglottic inflammation and, in some cases, diminution of the subglottic scar.

Surgical therapy

Surgical procedures for subglottic stenosis include the following:

Etiology

Congenital

Stenosis is said to be congenital in the absence of a history of intubation or other acquired causes. Congenital laryngeal webs account for approximately 5% of congenital anomalies of the larynx, with 75% occurring at the glottic level and the rest developing at the subglottic or supraglottic level. Most severe cases are diagnosed in childhood.

Acquired

Trauma is the most common cause of stenosis in children and adults. Approximately 90% of all cases of acquired chronic subglottic stenosis in children and adults result from endotracheal intubation. The reported rate of stenosis following intubation ranges from 0.9-8.3%.

Intubation causes injury at the level of the glottis due to pressure between the arytenoid cartilages. Intubation causes injury in the subglottis due to the complete cartilaginous ring or can cause injury distally in the trachea. Pressure and/or motion of the tube against the cartilage framework may cause ischemia and necrosis.

Duration of intubation is the most important factor in the development of stenosis. Severe injury has been reported after 17 hours, but it may occur much sooner. A 7-10 day period of intensive care unit (ICU) intubation is acceptable, but the risk of laryngotracheal injury increases drastically after that.

Size of the tube is also important. Tubes should be no larger than 7-8 mm in internal diameter for adult males and no larger than 6-7 mm in internal diameter for adult females. The size of the endotracheal tube needed correlates best with the patient's height.

Stenosis can also be secondary to a foreign body, to infection, to inflammation, or to chemical irritation. Respiratory epithelium is susceptible to injury. Initial edema, vascular congestion, and acute inflammation can progress to ulceration and local infection with growth of granulation tissue. Finally, fibroblast proliferation, scar formation, and contracture can occur and result in stenosis.

Systemic factors may increase the risk of injury and include the following:

Other causes include the following:

Chronic inflammatory diseases include the following:

A retrospective study by Fang et al found that among 41 patients with idiopathic subglottic stenosis who underwent esophageal pH impedance testing, 19 (46.3%) had gastroesophageal reflux disease, including 15 (36.6%) who had a predominantly upright reflux condition.[3]

A study by Gnagi et al found that time to diagnosis differed significantly between patients with acquired subglottic stenosis and those with idiopathic subglottic and tracheal stenosis. While 32% of the acquired stenosis patients were diagnosed within 3 months of symptom onset, just 2% of the other group were diagnosed within this time. The study involved a total of 160 patients.[4]

Pathophysiology

Congenital stenosis has two main types, membranous and cartilaginous.

In membranous stenosis, fibrous soft tissue thickening is caused by increased connective tissue or hyperplastic dilated mucus glands with absence of inflammation. Membranous stenosis is usually circumferential and may extend upward to include the true vocal folds.

In cartilaginous stenosis, a thickening or deformity of the cricoid cartilage most commonly occurs, causing a shelflike plate of cartilage and leaving a small posterior opening. Cartilaginous stenosis is less common than membranous stenosis.

Acquired subglottic stenosis is secondary to localized trauma to subglottic structures. Usually, injury is caused by endotracheal intubation or high tracheostomy tube placement. If irritation persists, the original edema and inflammation progress to ulceration and granulation tissue formation. This may or may not involve chondritis with destruction of the underlying cricoid cartilage and loss of framework support.

When the source of irritation is removed, healing occurs with fibroblast proliferation, scar formation, and contracture, leading to stenosis or complete occlusion of the airway.

A study by D’Oto et al indicated that in patients with idiopathic subglottic stenosis, the rates of tobacco use and type 2 diabetes mellitus are higher in persons aged 65 years or older than in younger individuals. This may demonstrate that idiopathic subglottic stenosis has a different pathophysiology in older patients than it does in persons below age 65 years. Nonetheless, although type 2 diabetes has been linked to delayed and aberrant wound healing, the investigators admit that because the incidence of diabetes tends to be higher in older individuals in general, these results may have limited clinical significance. However, the greater rate of current and former tobacco use in the elderly may also indicate aberrant healing as a source of the stenosis.[5]

Presentation

Adults with mild congenital stenosis are usually asymptomatic, and they are diagnosed after a difficult intubation or while undergoing endoscopy for other reasons.

Patients with acquired stenosis are diagnosed from a few days to 10 years or more following initial injury. The majority of cases are diagnosed within a year. Symptoms include the following:

Many patients would have been diagnosed with asthma and recurrent bronchitis prior to discovery of stenosis. A high index of suspicion is warranted with the onset of respiratory symptoms following intubation, regardless of the duration of intubation.

Indications

Indications for treatment are to improve compromised airways and progress toward decannulation. Speedy intervention prior to cartilage damage or scar contracture is preferred when the diagnosis is made early.

Relevant Anatomy

The subglottic area is circumferentially bound by the cricoid cartilage, which is part of the larynx. The adult trachea is 10-13 cm long and 17-24 mm in diameter and extends from the inferior border of the cricoid cartilage to the carinal spur.

The first tracheal cartilage is partly inset in the lower border of the cricoid and, on occasion, may be fused with it. All of the tracheal rings are incomplete posteriorly.

Primarily, arterial supply to the larynx comes from branches of the superior and inferior thyroid arteries. The superior thyroid artery sends a superior laryngeal branch through the thyrohyoid membrane. The inferior thyroid artery sends an inferior laryngeal branch with the recurrent laryngeal nerve to enter the larynx near the cricothyroid joint.

The tracheal blood supply is segmental. Branches of the inferior thyroid artery supply the upper trachea. Branches of the bronchial arteries, with contributions from subclavian, supreme intercostal, internal thoracic, and innominate arteries, supply the lower trachea. The branches arrive to the trachea via lateral pedicles.

Sensory innervation to the subglottic mucosa is by the recurrent laryngeal nerve. The thyroid gland is adherent to the trachea at the second and third tracheal rings, but the lateral lobes overlie the cricoid cartilage and can approximate the lower lateral thyroid laminae.

Contraindications

Most contraindications are relative and include the following:

Contraindications specific to long-term tracheostomy are debatable and include the following:

Contraindications reported for open repair include the following:

Laboratory Studies

In the absence of a history of prior trauma or when suggested by other findings, evaluate for inflammatory or infectious causes, including the following:

Imaging Studies

Radiography

Standard chest radiographs can often provide a great deal of information regarding the tracheal air column.

Anteroposterior filtered tracheal views and lateral soft tissue views of the neck provide specific information regarding the glottic/subglottic air column.

MRI

MRI is useful in evaluating the length and width of the stenotic region by means of coronal and sagittal views.

CT scanning

CT scanning is not as helpful as MRI because its views are generally only in the axial plane.

Thin cuts (1 mm) with sagittal and/or coronal reconstructions may be helpful, however. This is the preferred initial imaging study of the author.

Software allows virtual bronchoscopy, which may be helpful in assessing the airway and in surgical planning, prior to actually performing a procedure.

Other Tests

Flow-volume loops do not offer more specific information regarding stenosis than that gained from imaging. However, flow-volume loops may be helpful in monitoring for restenosis after intervention.

The use of pH probe testing has been helpful in identifying reflux as a contributing factor to the cause and recurrence of subglottic stenosis.  As previously mentioned, a retrospective study by Fang et al found that among 41 patients with idiopathic subglottic stenosis who underwent esophageal pH impedance testing, 19 (46.3%) had gastroesophageal reflux disease, including 15 (36.6%) who had a predominantly upright reflux condition.[3]

Diagnostic Procedures

Videostrobolaryngoscopy is extremely helpful in evaluating the glottic and supraglottic larynx for possible concomitant injury.

Visualization of the larynx by flexible fiberoptic or rigid telescopic (90- or 70-degree) scopes in the clinic is crucial to the evaluation of airway lesions.

Medical Therapy

Any underlying medical cause must be addressed (eg, infectious etiology, inflammatory causes such as granulomatosis with polyangiitis).

Antireflux management

This includes the following:

Use of systemic steroids in early stenosis is an option but has not been thoroughly investigated. In active inflammatory states of the subglottis, such as that manifesting as granulation tissue, inhaled steroids are of potential benefit (eg, fluticasone propionate [Flovent HFA 220 mcg], two puffs twice a day for 2 weeks; this is an off-label use based on the author's own experience).

In-office injection of steroids

Transcervical or transoral (via a channeled scope) injection of steroids such as triamcinolone acetonide (Kenalog-40) is now being used by many centers, with good early results in the control of subglottic inflammation and, in some cases, diminution of the subglottic scar.

The interval of injection has not been fully elucidated and varies from once a month for 6 months, then every 6 months afterward as needed (Simpson, CB; San Antonio, Texas; personal communication), to every 3 months as needed (author's experience). Although early reports have suggested that this approach is safe and effective, the steroids' long-term effects on cartilage integrity is unknown.[6, 7, 8]

Steroid injection may offer improvement in surgical interval or even serve as a primary treatment in minor-grade stenosis in adults.

A retrospective study by Naunheim et al indicated that serial intralesional steroid injections (SILSI) can improve voice-related quality of life (V-RQOL) in patients with idiopathic subglottic stenosis. Of 143 “encounters with full data” in association with patients who received SILSI only, the investigators found that 70 (49%) demonstrated improvement in V-RQOL, 40 (28%) revealed no change, and 33 (23.0%) showed a worsening in V-RQOL. In addition, the study suggested that a significant, albeit weak, correlation exists between peak expiratory flow percentage and V-RQOL in idiopathic subglottic stenosis.[9]

Trimethoprim-sulfamethoxazole

As an adjunct to medical therapy such as inhaled corticosteroids, some authors have suggested a useful role for trimethoprim-sulfamethoxazole (Bactrim) for the management of subglottic stenosis in the postoperative period.[10]  However, further review has found that adding trimethoprim-sulfamethoxazole has not had any significant effect on prolonging the interval between surgeries in either the short or long term.[11]  A strong recommendation for adding this antibiotic to the management of subglottic stenosis cannot be made at this time unless it is to be used for directed management of an infection.

Surgical Therapy

Surgical therapy can include the following:

Endoscopic repair

Endoscopic repair is not indicated following blunt or penetrating neck trauma.

It is advocated as a preferred initial approach in chronic subglottic stenosis

Several procedures may be required to obtain the desired result.

A carbon dioxide laser is very useful in this setting, or a neodymium:yttrium-aluminum-garnet (Nd:YAG) laser can be used.

Airway management may be accomplished via supraglottic jet ventilation, intermittent apneic technique, spontaneous ventilation, or a laser-safe tube through an already established tracheotomy tract.

Triamcinolone injected into the stenotic wound or a topical aziridine compound such as mitomycin C has the potential to reduce fibrosis and can be used in the operative setting.

Growing evidence shows dilation of the stenotic area as being very helpful. Traditional rigid dilators ("Olive" or Jackson tracheal dilators) are effective in dilation, but they often shear the mucosa, creating a potential for cicatricial contraction. Newer balloon dilators may offer an advantage of dilation without shear.

Open repair

Open repair is indicated following failure of the endoscopic approach when the extent of stenosis is severe or factors are unfavorable for this approach.

Choose the specific technique based on the length of the resection, the need for cartilage, and the need for mucosal coverage. Stent placement is required in some procedures.

Other procedures

These include the following:

A study by Deckard et al indicated that, as in pediatric patients, two-stage laryngotracheal reconstruction (LTR) can be successfully used to treat subglottic stenosis in adults, offering a means to avoid the complications of cricotracheal resection. In the study, 14 adult patients, most of whom had high-grade (grade III or IV) stenosis, underwent LTR, with 12 of them achieving decannulation. One of these patients, however, subsequently required salvage surgery and was decannulated again only after cricotracheal resection. Thus, 11 patients (79%) achieved decannulation with LTR alone.[12]

Preoperative Details

The length of stenosis, its severity, the involvement of cartilage, and the degree of scar maturity must be known prior to any attempts at repair. The endoscopic approach has a high failure rate if the stenosis is longer than 1.0-1.4 cm.

Detect any proximal or distal injuries (eg, supraglottic stenosis, posterior glottic scar, arytenoid fixation, distal tracheal stenosis).

Use imaging and endoscopic investigation. Begin antireflux management approximately 1 month prior to repair.

Intraoperative Details

In the endoscopic management of the stenosis, mitomycin-C has become routinely used. The concentration is usually 0.4 mg/mL and is applied topically on a cottonoid pledget. The length of application varies from 2-3 repeat applications of 2 minutes each to a single application of 5 minutes.

The handling and disposal of the mitomycin-C should be per the hospital protocol for chemotherapeutic agents. Care should be taken to avoid contact with unprotected skin.

Postoperative Details

Endoscopic approach

This involves the following:

Open approach

This involves the following:

Follow-up

Follow-up includes the following:

The use of personal ambulatory spirometry has been found to be valuable in patient self-monitoring, being a good indicator of postsurgical outcomes and for the recurrence of stenosis. (However, it has not been useful in predicting the degree of stenosis.) Ambulatory spirometry may be an especially useful adjunct for persons who cannot easily obtain physical evaluation, such as rural populations who would require long travel times, persons who are poorly mobile, and individuals with transportation issues. Careful and thorough education is essential if this method of surveillance is to be relied on, but patients have reported satisfaction, with ease of use.[13]

Complications

Complications include the following:

Outcome and Prognosis

Overall goals are improvement of airway function and preservation of laryngeal function. The endoscopic approach was found to be successful in 57-90% of cases. Intraluminal stents were found to be successful in 80% of cases.

In a study of 109 patients with subglottic stenosis, D’Andrilli et al reported that the long-term results of laryngotracheal resection demonstrate it to be the definitive curative treatment for the condition, with 94.5% of the patients having good to excellent outcomes from the surgery.[14]

Open Approach

End-to-end anastomosis was found to be successful in 80-90% of cases. Mortality was reported at 10-20%; it has decreased with experience. Morbidity is 20-50%, secondary to the effect on laryngeal function and swallowing.

Augmentation Techniques

Successful case rates of 60-96% have been reported. Grafts are susceptible to infection, resorption, displacement, and extrusion.

Author

James David Garnett, MD, FACS, Associate Professor, Department of Otolaryngology-Head and Neck Surgery, Director of Voice and Swallowing Center, University of Kansas Health System

Disclosure: Nothing to disclose.

Specialty Editors

Francisco Talavera, PharmD, PhD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Robert M Kellman, MD, Professor and Chair, Department of Otolaryngology and Communication Sciences, State University of New York Upstate Medical University

Disclosure: Nothing to disclose.

Chief Editor

Arlen D Meyers, MD, MBA, Emeritus Professor of Otolaryngology, Dentistry, and Engineering, University of Colorado School of Medicine

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Cerescan; Neosoma; MI10;Invitrocaptal,Medtechsyndicates<br/>Received income in an amount equal to or greater than $250 from: Neosoma; Cyberionix (CYBX);MI10;Invitrocaptal;MTS<br/>Received ownership interest from Cerescan for consulting for: Neosoma, MI10 advisor.

Additional Contributors

Anthony P Sclafani, MD, Professor of Otolaryngology, Weill Cornell Medical College; Director of Facial Plastic Surgery, Department of Otolaryngology-Head and Neck Surgery, Center for Facial Plastic Surgery, Weill Cornell Medicine

Disclosure: Nothing to disclose.

References

  1. Moroni L, Giudice L, Lanzillotta M, et al. Role of systemic immunosuppression on subglottic stenosis in granulomatosis with polyangiitis: Analysis of a single-centre cohort. Eur J Intern Med. 2023 Aug. 114:108-12. [View Abstract]
  2. McQueen CT, Wellendorf TG, Henrich D, et al. Subglottic stenosis: A complication of percutaneous tracheotomy. Otolaryngol Head Neck Surg. 1999. 120(4):543-5. [View Abstract]
  3. Fang H, Codipilly DC, Ravi K, Ekbom DC, Kasperbauer JL, Halland M. Gastroesophageal Reflux Characteristics and Patterns in Patients with Idiopathic Subglottic Stenosis. Gastroenterol Res Pract. 2018. 2018:8563697. [View Abstract]
  4. Gnagi SH, Howard BE, Anderson C, Lott DG. Idiopathic Subglottic and Tracheal Stenosis: A Survey of the Patient Experience. Ann Otol Rhinol Laryngol. 2015 Sep. 124 (9):734-9. [View Abstract]
  5. D'Oto A, Baker H, Mau T, Childs LF, Tibbetts KM. Characteristics of Idiopathic Subglottic Stenosis in the Elderly. Laryngoscope. 2023 May 11. [View Abstract]
  6. Bertelsen C, Shoffel-Havakuk H, O'Dell K, Johns MM 3rd, Reder LS. Serial In-Office Intralesional Steroid Injections in Airway Stenosis. JAMA Otolaryngol Head Neck Surg. 2018 Mar 1. 144 (3):203-10. [View Abstract]
  7. Hoffman MR, Coughlin AR, Dailey SH. Serial office-based steroid injections for treatment of idiopathic subglottic stenosis. Laryngoscope. 2017 Nov. 127 (11):2475-81. [View Abstract]
  8. Franco RA Jr, Husain I, Reder L, Paddle P. Awake serial intralesional steroid injections without surgery as a novel targeted treatment for idiopathic subglottic stenosis. Laryngoscope. 2018 Mar. 128 (3):610-7. [View Abstract]
  9. Naunheim MR, Puka E, Choksawad K, Franco RA. Voice-Related Quality of Life in Idiopathic Subglottic Stenosis: Effect of Serial Intralesional Steroid Injections. Laryngoscope. 2020 Sep 9. [View Abstract]
  10. Maldonado F, Loiselle A, Depew ZS, et al. Idiopathic subglottic stenosis: an evolving therapeutic algorithm. Laryngoscope. 2014 Feb. 124 (2):498-503. [View Abstract]
  11. Hoffman MR, Patro A, Huang LC, et al. Impact of Adjuvant Medical Therapies on Surgical Outcomes in Idiopathic Subglottic Stenosis. Laryngoscope. 2021 Dec. 131 (12):E2880-6. [View Abstract]
  12. Deckard N, Yeh J, Soares DJ, Criddle M, Stachler R, Coticchia J. Utility of two-stage laryngotracheal reconstruction in the management of subglottic stenosis in adults. Ann Otol Rhinol Laryngol. 2013 May. 122 (5):322-9. [View Abstract]
  13. Abdullah A, Alrabiah A, Habib SS, et al. The Value of Spirometry in Subglottic Stenosis. Ear Nose Throat J. 2019 Feb. 98 (2):98-101. [View Abstract]
  14. D'Andrilli A, Maurizi G, Andreetti C, et al. Long-term results of laryngotracheal resection for benign stenosis from a series of 109 consecutive patients. Eur J Cardiothorac Surg. 2016 Jul. 50 (1):105-9. [View Abstract]

Preoperative view of subglottic stenosis via an endoscopic approach.

Postoperative view of subglottic stenosis after four-quadrant carbon dioxide laser division and endoscopic balloon dilation. Note the excellent view of the distal airway.

Preoperative view of subglottic stenosis via an endoscopic approach.

Postoperative view of subglottic stenosis after four-quadrant carbon dioxide laser division and endoscopic balloon dilation. Note the excellent view of the distal airway.